Prevalence of chronic kidney disease of non-Traditional causes in patients on hemodialysis in southwest Guatemala

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 39, Issue 4, 2016, Pages 186-193

  Laux, Timothy S ^a   Barnoya, Joaquin ^b   Cipriano, Ever ^c   Herrera, Erick ^c   Lopez, Noemi ^d   Polo, Vicente Sanchez ^c   Rothstein, Marcos ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c Unidad de Investigación Instituto Guatemalteco de Seguridad Social Ciudad de Guatemala   (Guatemala)

^d WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Central america; Dialysis; Guatemala; Renal insufficiency, chronic

Indexed keywords

DISEASE PREVALENCE; HEALTH RISK; HOSPITAL SECTOR; HYPERTENSION; OBESITY; OCCUPATIONAL EXPOSURE; RISK FACTOR; TRAVEL TIME;

EL SALVADOR [CENTRAL AMERICA]; GUATEMALA [CENTRAL AMERICA];

CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; EL SALVADOR; GUATEMALA; HEMODIALYSIS; HUMAN; PREVALENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

CROSS-SECTIONAL STUDIES; EL SALVADOR; GUATEMALA; HUMANS; PREVALENCE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84988946612     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lunyera J, Mohottige D, Isenburg MV, Jeuland M, Patel UD, Stanifer JW. CKD of Uncertain Etiology: A Systematic Review. Clin J Am Soc Nephrol. 2016;11:85-379.
2. Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman D, editors. Mesoamerican Nephropathy: Report from the First International Research Workshop on MeN. San Jose, Costa Rica: Central American Institute for Studies on Toxic Substances (IRET-UNA), Program on Work, Environment and Health in Central American (SALTRA); 2013.
3. Correa-Rotter R, Wesseling C, Johnson RJ. CKD of unknown origin in Central America: The case for a Mesoamerican nephropathy. Am J Kidney Dis. 2014;63:20-506.
4. Wijkstrom J, Leiva R, Elinder CG, Leiva S, Trujillo Z, Trujillo L, et al. Clinical and pathological characterization of mesoamerican nephropathy: A new kidney disease in central america. Am J Kidney Dis. 2013;62:18-908.
5. Nanayakkara S, Komiya T, Ratnatunga N, Senevirathna ST, Harada KH, Hitomi T, et al. Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka. Environ Health Prev Med. 2012;17:21-213.
6. Lopez-Marin L, Chavez Y, Garcia XA, Flores WM, Garcia YM, Herrera R, et al. Histopathology of chronic kidney disease of unknown etiology in Salvadoran agricultural communities. MEDICC Rev. 2014; 16:49-54.
7. Torres C, Aragon A, Gonzalez M, Lopez I, Jakobsson K, Elinder CG, et al. Decreased kidney function of unknown cause in Nicaragua: A community-based survey. Am J Kidney Dis. 2010;55:96-485.
8. Sanoff SL, Callejas L, Alonso CD, Hu Y, Colindres RE, Chin H, et al. Positive association of renal insufficiency with agriculture employment and unregulated alcohol consumption in Nicaragua. Ren Fail. 2010;32: 77-766.
9. O'Donnell JK, Tobey M, Weiner DE, Stevens LA, Johnson S, Stringham P, et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol Dial Transplant 2011;26:805-2798.
10. Laux TS, Bert PJ, Barreto Ruiz GM, Gonzalez M, Unruh M, Aragon A, et al. Nicaragua revisited: evidence of lower prevalence of chronic kidney disease in a high-Altitude, coffee-growing village. J Nephrol. 2012;25:40-533.
11. Orantes CM, Herrera R, Almaguer M, Brizuela EG, Nunez L, Alvarado NP, et al. Epidemiology of chronic kidney disease in adults of Salvadoran agricultural communities. MEDICC Rev. 2014;16:23-30.
12. Peraza S, Wesseling C, Aragon A, Leiva R, Garcia-Trabanino RA, Torres C, et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis. 2012;59:40-531.
13. Laws RL, Brooks DR, Amador JJ, Weiner DE, Kaufman JS, Ramirez-Rubio O, et al. Changes in kidney function among Nicaraguan sugarcane workers. Int J Occup Environ Health. 2015;21:50-241.
14. Trabanino RG, Aguilar R, Silva CR, Mercado MO, Merino RL. End-stage renal disease among patients in a referral hospital in El Salvador. Rev Panam Salud Publica. 2002;12:6-202.
15. Krznaric R. The Limits on Pro-poor Agricultural Trade in Guatemala: Land, Labour and Political Power. J Hum Dev. 2006;7:35-111.
16. Laux TS, Barnoya J, Guerrero DR, Rothstein M. Dialysis enrollment patterns in Guatemala: evidence of the chronic kidney disease of non-Traditional causes epidemic in Mesoamerica. BMC Nephrol. 2015;16:54.
17. Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, McGill J, Mitch WE, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study. Kidney Int. 2003;63:507-1499.
18. Phimda K, Hoontrakul S, Suttinont C, Chareonwat S, Losuwanaluk K, Chueasuwanchai S, et al. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother. 2007;51:63-3259.
19. CPC.UNC.edu [Internet]. United States Agency for International Development (USAID): Quick Poverty Score Toolkit User's Guide - Guatemala [cited 2015 Oct]. Available from: http://www.cpc.unc.edu/measure/tools/poverty/quick-poverty-score/QPS-Guatemala-MS-09-35D.pdf.
20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150: 12-604.
21. Rahman M, Fu P, Sehgal AR, Smith MC. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis. 2000;35: 65-257.
22. Weiner DE, McClean MD, Kaufman JS, Brooks DR. The Central American epidemic of CKD. Clin J Am Soc Nephrol. 2013;8:11-504.
23. Oj.Gob.Gt [Internet]. Guatemala National Institute of Statistics: Projection of Population by Municipality, 2008-2020 [cited 2015 Oct]. Available from: http://www.oj.gob.gt/estadisticaj/files/poblacion-Total-por-municipio1.pdf.
24. Delgado Cortez O. Heat stress assessment among workers in a Nicaraguan sugarcane farm. Glob Health Action. 2009;2: 10.3402/gha.v2i0.2069.
25. Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernandez CE, Bayarre H, et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC Rev. 2011;13:14-22.
26. Crowe J, Moya-Bonilla JM, Roman- Solano B, Robles-Ramirez A. Heat exposure in sugarcane workers in Costa Rica during the non-harvest season. Glob Health Action. 2010;3:10.3402/gha.v3i0. 5619.
27. Wesseling C, van Wendel de Joode B, Crowe J, Rittner R, Sanati, NA, Hogstedt C, et al. Mesoamerican nephropathy: geographical distribution and time trends of chronic kidney disease mortality between 1970 and 2012 in Costa Rica. Occup Environ Med. 2015;72:21-714.
28. Miranda JJ, Herrera VM, Chirinos JA, Gomez LF, Perel P, Pichardo R, et al. Major cardiovascular risk factors in Latin America: A comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO). PLoS One. 2013;8:e54056.
29. Johnson RJ, Glaser J, Sanchez-Lozada LG. Chronic kidney disease of unknown etiology: A disease related to global warming? MEDICC Rev. 2014;16:79-80.
30. PAHO.org [Internet]. Washington D.C.: Chronic kidney diseases (N18) and Renal failure (N17-N19) mortality, countries of the Americas (Age-standardized mortality rate per 100, 000 population) [cited 2015 Oct]. Available from: http://www.paho.org/hq/index.php?option=com-content&view=article&id=9402.
31. Tonelli M, Pannu N, Manns B. Oral phosphate binders in patients with kidney failure. N Engl J Med. 2010;362: 24-1312.
32. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:30-519.
33. PAHO.org [Internet]. Washington D.C.: Health Systems Profile Guatemala [cited 2015 Oct]. Available from: http://www2.paho.org/hq/dmdocuments/2010/Health-System-Profile-Guatemala-2007.pdf.